drugset / Trial / NCT00453401
Safety, Pharmacokinetics, and Efficacy Study of NB-001 to Treat Recurrent Herpes Labialis
RandomizedParallel-groupDouble-blindTreatment
Summary
Purpose of this study is to determine the safety and efficacy of topical applications of NB-001 as compared to placebo for the treatment of recurrent herpes labialis.
Timeline
- Start
- 2007-02
- Primary completion
- 2007-12
- Completion
- 2007-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | NB-001 | Other / unclassified | 0.1 % | Topical |
| Subject | NB-001 | Other / unclassified | 0.3 % | Topical |
| Subject | NB-001 | Other / unclassified | 0.5 % | Topical |